A Clinical Study of iNSC Intervent Cerebral Hemorrhagic Stroke
NCT03725865 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2018-10-31
Summary
This is a single centre、single arm、open-label，to investigate the safety and efficacy of induction of neural stem cells transplantation in the brain
Conditions
- Stroke, Ischemic
Interventions
- BIOLOGICAL
-
Induction of neural stem cells
Brain injection iNSC
Sponsors & Collaborators
-
Allife Medical Science and Technology Co., Ltd.
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 30 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-31
- Primary Completion
- 2019-03-31
- Completion
- 2019-03-31
More Related Trials
-
Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke
NCT04811651 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Huatuo Zaizao Pills in Improving of Neural Function in Acute Ischemic Stroke
NCT01758536 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy Study of CD34 Stem Cell in Chronic Stroke Patients
NCT00950521 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study to Investigate the Safety and Efficacy of MLC601 in 150 Iranian Patients After Stroke
NCT01336153 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety and Effective Study of Ginkgolides Diterpene Lactone Meglumine Injection in the Treatment of Ischemic Stroke.
NCT02526225 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke
NCT06861426 ·Status: NOT_YET_RECRUITING
-
Acupuncture Intervention to Improve Neurological Function and Anti-inflammatory Effect in Acute Ischemic Stroke (ANAIS)
NCT03097055 ·Status: COMPLETED ·Phase: NA
-
Analyzing the Pharmacodynamic Substances and the Effects of Xingnaojing for Mild-to-Severe Acute Ischemic Stroke
NCT05559307 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of HC-58 in Upper Limb Hemiplegic Patients After Stroke
NCT01623622 ·Status: COMPLETED ·Phase: PHASE2
-
FMRI in Monitoring Intracerebral Stem Cell Implantation for Chronic Stroke Patients
NCT01249287 ·Status: UNKNOWN
-
Statin for Neuroprotection in Spontaneous Intracerebral Hemorrhage
NCT04857632 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Xingnaojing for Mild-to-severe Acute Ischemic Stroke
NCT04150835 ·Status: UNKNOWN ·Phase: PHASE4
-
A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cell for the Treatment of Stroke.
NCT01832428 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
An Open-labeled Phase II Study to Evaluate the Efficacy and Safety of GXNPC-1 in Patients with Chronic Stroke
NCT04088149 ·Status: COMPLETED ·Phase: PHASE2
-
Autologous Endothelial Progenitor Cells Transplantation for Chronic Ischemic Stroke
NCT02605707 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
China Stroke Registry for Patients With Traditional Chinese Medicine
NCT04921397 ·Status: UNKNOWN
-
Protein Supplementation for Chronic Stroke Treatment
NCT03637270 ·Status: COMPLETED ·Phase: NA
-
The Investigation of Therapeutic Effect and Platelet Activity After ILIB for Ischemic Stroke Patient
NCT05456750 ·Status: COMPLETED ·Phase: NA
-
Induced Pluripotent Stem Cells-derived Small Extracellular Vesicles May Promote Neurological Function and Improve Cognitive Impairment in Acute Ischemic Stroke Patients
NCT07145294 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Cohort Study for Severe Ischaemic Stroke
NCT03222024 ·Status: COMPLETED
-
Establishment and Evaluation to the Effects of a Clinical Pathway for Acute Ischemic Stroke
NCT00966316 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study of Angong Niuhuang Pill and Acupuncture on PSCI Angong Niuhuang Pill Combined With Supervised Pulse Music Electroacupuncture on Cognitive Impairment After Ischemic Stroke
NCT05731310 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Efficacy and Safety of LongShengZhi Capsule on Functional Recovery After Acute Ischaemic Stroke (LONGAN)
NCT05277311 ·Status: UNKNOWN ·Phase: NA
-
Quality Control Project of Stroke in Liaoning Province
NCT03507517 ·Status: COMPLETED
-
UCMSCs as Treatment for Patients With Acute Ischemic Stroke (Stroke Neuroncell-EX)
NCT06129175 ·Status: RECRUITING ·Phase: PHASE2/PHASE3